SCHEMBL5066638

SCHEMBL5066638

c1ccc(CCc2ccc3c(c2)CCO3)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.53
MAOB P27338 3/20 0.53
KDM1A O60341 1/20 0.53
NPC1 O15118 1/20 0.53
POLB P06746 1/20 0.53
RAB9A P51151 1/20 0.53
CHRM5 P08912 3/20 0.47
CHRM1 P11229 3/20 0.47
KCNH2 Q12809 2/20 0.47
CHRM2 P08172 2/20 0.47
CHRM4 P08173 2/20 0.47
CHRM3 P20309 2/20 0.47
ADRB2 P07550 1/20 0.47
ADRB1 P08588 1/20 0.47
ADRA2A P08913 1/20 0.47
DRD2 P14416 1/20 0.47
KCNE1 P15382 1/20 0.47
ADRA2B P18089 1/20 0.47
ADRA2C P18825 1/20 0.47
HRH2 P25021 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4750630 0.84 RAB9A (0.45) MAOAMAOBKDM1ANPC1POLB
SCHEMBL22495318 0.84 POLB (0.55) MAOAMAOBKDM1ANPC1POLB
SCHEMBL29997560 0.81 RAB9A (0.45) MAOAMAOBKDM1ANPC1POLB
SCHEMBL292900 0.81 RAB9A (0.45) MAOAMAOBKDM1ANPC1POLB
SCHEMBL29791018 0.81 PRKCI (0.49) MAOAMAOBKDM1ANPC1POLB
SCHEMBL2035570 0.81 PRKCI (0.49) MAOAMAOBKDM1ANPC1POLB
SCHEMBL1276487 0.81 RAB9A (0.46) MAOAMAOBKDM1ANPC1POLB
SCHEMBL2773998 0.81 TAAR1 (0.56) MAOAMAOBKDM1ANPC1POLB
SCHEMBL1317917 0.81 RAB9A (0.45) MAOAMAOBKDM1ANPC1POLB
SCHEMBL29786197 0.81 RAB9A (0.45) MAOAMAOBKDM1ANPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979324-A2 NOVEL 2-AMINO-IMIDAZOLE-4-ONE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT TO BE USED IN THE TREATMENT OF COGNITIVE IMPAIRMENT, ALZHEIMER'S DISEASE, NEURODEGENERATION AND DEMENTIA Astra Zeneca AB (SE) 2008-10-15 EP claimed
WO-2007058602-A2 NOVEL 2-AMINO-IMIDAZOLE-4-ONE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT TO BE USED IN THE TREATMENT OF COGNITIVE IMPAIRMENT, ALZHEIMER’S DISEASE, NEURODEGENERATION AND DEMENTIA. ASTRAZENECA AB (SE) 2007-05-24 WO claimed